Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J O'Rourke

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cancer|September 15, 1992
Testicular relapse in adult acute myelogenous leukemiaD W Shaffer, H A Burris, T J O'Rourke
American Journal of Hematology|February 1, 1996
Acute myeloid leukemia evolving from essential thrombocythemia in two patients treated with hydroxyureaJ L Furgerson, S J Vukelja, W J Baker, et al.
Oncology Nursing Forum|June 1, 1997
Expectations and experiences of patients with cancer participating in phase I clinical trialsL H Yoder, T J O'Rourke, A Etnyre, et al.
Urologic Oncology|January 14, 2011
Interobserver variability in prostate cancer specific survivalJ Y Clark, P K Lillis, T J O'Rourke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group trial 9246O W Press, M LeBlanc, T J O'Rourke, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
New anticancer agentsT D Brown, H A Burris, K A Havlin, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1992
New anticancer agentsT D Brown, H A Burris, J R Eckardt, et al.
American Journal of Hematology|November 1, 1991
Hemophagocytic syndrome: a cause of pancytopenia in human ehrlichiosisK C Abbott, S J Vukelja, C E Smith, et al.
Anti-Cancer Drugs|October 1, 1994
Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812)T J O'Rourke, G R Weiss, P New, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
New anticancer agentsT D Brown, K A Havlin, J M Koeller, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cancer|September 15, 1992
Testicular relapse in adult acute myelogenous leukemiaD W Shaffer, H A Burris, T J O'Rourke
American Journal of Hematology|February 1, 1996
Acute myeloid leukemia evolving from essential thrombocythemia in two patients treated with hydroxyureaJ L Furgerson, S J Vukelja, W J Baker, et al.
Oncology Nursing Forum|June 1, 1997
Expectations and experiences of patients with cancer participating in phase I clinical trialsL H Yoder, T J O'Rourke, A Etnyre, et al.
Urologic Oncology|January 14, 2011
Interobserver variability in prostate cancer specific survivalJ Y Clark, P K Lillis, T J O'Rourke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group trial 9246O W Press, M LeBlanc, T J O'Rourke, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
New anticancer agentsT D Brown, H A Burris, K A Havlin, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1992
New anticancer agentsT D Brown, H A Burris, J R Eckardt, et al.
American Journal of Hematology|November 1, 1991
Hemophagocytic syndrome: a cause of pancytopenia in human ehrlichiosisK C Abbott, S J Vukelja, C E Smith, et al.
Anti-Cancer Drugs|October 1, 1994
Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812)T J O'Rourke, G R Weiss, P New, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
New anticancer agentsT D Brown, K A Havlin, J M Koeller, et al.
Pageof 2